Data structure of the thematic analysis
| First-order concepts (representative evidence) | Second-order themes | Aggregate dimensions |
|---|---|---|
| Proximity to healthcare facilities; delivery-time reduction; delivery accuracy with digital pedigree; AI-driven demand sensing; robust interconnected network; smart cold-chain monitoring; real-time inventory visibility; safe handling of medicines | Location and distribution proximity; delivery accuracy; availability of supplies; robust supply network; cold storage facilities; inventory visibility; handling quality | Operational and logistics factors |
| Geopolitical instability and tariffs; regionalization and friend-shoring; labour strikes at ports and distribution centres; automated dual-hub rerouting | Political risk; labour disruption | Risk and disruption factors |
| Regulatory track record and GMP audit history; financial vetting of partners; buyer and supplier bargaining leverage; CDMO switching costs | Organizational experience; financial stability of partners; bargaining power | Supplier and organizational capability factors |
| Specialized temperature-controlled storage cost; scalable automation offsets; predictive-analytics-driven cost reduction; local data processing | Warehousing cost; technology-enabled cost optimization | Financial and cost factors |
| Real-time automated regulatory reporting; ESG due diligence in certification; market lockout on non-compliance | Governmental rules and regulations; quality certification and health safety | Governance and regulatory factors |
| Emerging technologies as supply-chain nervous system; AI and digital twins for cognitive orchestration; bio-digital-twin what-if simulation; quantum-resistant encryption and immutable ledgers | Technology innovation and IT capability; bio-digital twin compatibility; quantum-resistant encryption | Technology and digital transformation factors |
| Responsible sourcing and anti-diversion compliance; pharmacovigilance; ethical sourcing linked to investor confidence; psychedelic precursor ethics | Ethical sourcing and pharmacovigilance | Ethical and emerging pharmaceutical factors |
| First-order concepts (representative evidence) | Second-order themes | Aggregate dimensions |
|---|---|---|
| Proximity to healthcare facilities; delivery-time reduction; delivery accuracy with digital pedigree; AI-driven demand sensing; robust interconnected network; smart cold-chain monitoring; real-time inventory visibility; safe handling of medicines | Location and distribution proximity; delivery accuracy; availability of supplies; robust supply network; cold storage facilities; inventory visibility; handling quality | Operational and logistics factors |
| Geopolitical instability and tariffs; regionalization and friend-shoring; labour strikes at ports and distribution centres; automated dual-hub rerouting | Political risk; labour disruption | Risk and disruption factors |
| Regulatory track record and | Organizational experience; financial stability of partners; bargaining power | Supplier and organizational capability factors |
| Specialized temperature-controlled storage cost; scalable automation offsets; predictive-analytics-driven cost reduction; local data processing | Warehousing cost; technology-enabled cost optimization | Financial and cost factors |
| Real-time automated regulatory reporting; | Governmental rules and regulations; quality certification and health safety | Governance and regulatory factors |
| Emerging technologies as supply-chain nervous system; | Technology innovation and | Technology and digital transformation factors |
| Responsible sourcing and anti-diversion compliance; pharmacovigilance; ethical sourcing linked to investor confidence; psychedelic precursor ethics | Ethical sourcing and pharmacovigilance | Ethical and emerging pharmaceutical factors |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.